Jörg F. Löffler is a Full Professor of Metal Physics and Technology at the Department of Materials, ETH Zürich , where he has been since 2003. He previously served as Chairman of the Department (2010–2013) and holds Adjunct Professor positions at Tohoku University (Japan) and a Visiting Faculty role at Caltech. His research focuses on bulk metallic glasses , metallic biomaterials , and magnetic materials , combining synthesis, characterization, and applications in biomedical and structural contexts. Educations : Studied Physics and Materials Science at Saarland University (Germany), earned his doctorate at ETH Zurich and Paul Scherrer Institute on magnetism and neutron scattering (1997). Research Trends : Recent work explores additive manufacturing (e.g., laser powder bed fusion), biodegradable magnesium alloys for implants, and magneto-structural coupling in metallic glasses. Collaborative efforts integrate in situ analysis with computational modeling. Scientific Awards : International Magnesium Science and Technology Award (2023) MRS Fellow (2021) DGM 'Breakthrough' Prize (2016) Masing Memorial Prize (2005) ETH Zurich Medal (1998) Alexander von Humboldt Fellowship (1998-2001) Löffler advises the Department of Materials Science and Engineering at UC Davis and serves on editorial boards. His group at ETH Zürich investigates advanced metallic materials using synchrotron radiation and neutron scattering facilities.
Zakia Hammal is an Assistant Research Professor with dual appointments at Carnegie Mellon University, holding positions in the Robotics Institute within the School of Computer Science and the Department of Biomedical Engineering in the College of Engineering. Her work bridges computer science, machine learning, artificial intelligence, and social/behavioral psychology to advance computational models for human behavior analysis. Dr. Hammal's educational background includes a PhD in Computer Science, a Master of Artificial Intelligence and Algorithmic with specialization in Image Processing, and an Engineer's degree in Computer Science with specialization in Computer Systems. Her academic journey has positioned her at the intersection of technical expertise and healthcare applications. Her research focuses on multimodal human behavior modeling in social interaction, with particular emphasis on health informatics and affective computing (Emotion AI). Dr. Hammal's work has pioneered computational models for multimodal assessment of psychiatric disorders, including depression severity evaluation, automatic pain intensity measurement, assessment of expressiveness in children with facial abnormalities, analysis of non-verbal communication in mother-infant interaction, and identification of behavioral markers in autism spectrum disorder. Her approach integrates computer vision, machine learning, and behavioral psychology to create systems that can objectively measure human behaviors that are often subjective in clinical settings. Analysis of her recent publications reveals a consistent trajectory toward more sophisticated multimodal approaches to healthcare challenges, particularly in pain assessment and mental health diagnostics. Her work increasingly emphasizes interpretable AI models that can translate complex behavioral patterns into clinically meaningful insights, with growing attention to applications for vulnerable populations including infants, elderly patients, and those with craniofacial abnormalities or autism spectrum disorder. Women in AI Awards North America 2023 – AI Researcher of the Year Award Outstanding Reviewer Award at FG 2015 Best Paper award at ACII 2015 Outstanding Paper award at ICMI 2012 Dr. Hammal has secured significant research funding, primarily from the U.S. National Institutes of Health, including an R01 grant for developing a Multimodal Behavioral AI platform for pain assessment and management, and additional grants for automatic pain assessment in older adults with dementia. Her leadership extends to mentoring through her involvement in organizing workshops and conferences that train the next generation of researchers in affective computing and health informatics. As an active leader in her field, Dr. Hammal serves as ACM ICMI Steering Board Committee Member, Associate Editor for IEEE Transactions on Affective Computing and IEEE Transactions on Multimedia, and has organized numerous influential workshops including the International Workshop on Automated Assessment of Pain and Face and Gesture Analysis for Health Informatics. She is set to serve as Program Chair for FG 2025, ACII 2025, and ICMI 2026, demonstrating her growing influence in shaping the future direction of research in multimodal interaction and affective computing.
Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.
Joshua B. Gross is an Associate Professor in the Department of Biological Sciences at the University of Cincinnati, where he has been conducting research since 2010. His work focuses on evolutionary biology, particularly using the Mexican cavefish ( Astyanax mexicanus ) as a model system to study adaptation to extreme environments. Dr. Gross received his academic training at prestigious institutions: Ph.D. in Organismic and Evolutionary Biology from Harvard University (2005) M.S. with Distinction in Biological Sciences from University of Denver (2001) B.A. in Psychology from Miami University (1995) Dr. Gross's research explores the genetic and developmental basis of evolutionary changes, with a focus on how organisms adapt to extreme environments. His primary model system is the Mexican cavefish ( Astyanax mexicanus ), which exists in both surface-dwelling (with eyes and pigmentation) and cave-dwelling (blind and depigmented) forms. His work integrates quantitative genetics, transcriptomics, and phenotypic analysis to understand the genetic changes underlying cave adaptation, including both regressive traits (like eye loss) and constructive traits (like enhanced taste systems). Analysis of Dr. Gross's recent publications reveals a strong focus on sensory adaptation and craniofacial evolution in cavefish. His work has increasingly incorporated genomic and transcriptomic approaches to understand how cavefish adapt to low-oxygen environments, changes in sensory systems (particularly taste and lateral line), and craniofacial modifications. There's a clear trajectory toward understanding the integration between different biological systems, such as how sensory neuromasts influence skeletal development. Dr. Gross has received several notable awards and recognitions: National Academies Education Fellow in the Life Sciences (2014-2015) Young Investigator Winner, Sigma Xi, University of Cincinnati Chapter (2016) Honorable Mention, Excellence in Doctoral Mentoring Award Nominated for 2018 Dean's Award for Innovative Instruction Young Anatomist's Publication Award from the American Association of Anatomists (2004) As a principal investigator, Dr. Gross has secured substantial funding from the National Science Foundation and National Institutes of Health, including multiple R01 grants from NIH and major awards from NSF. His current projects include "The developmental basis for sensory-skeletal integration: The osteo-inductive role of neuromasts" (NSF IOS-2205928, 2022-2026) and "The constructive evolution of gustation: Molecular, organismal and environmental attributes of taste tuning" (NSF DEB-2343857, 2024-2028). He has mentored numerous undergraduate and graduate students through research projects and has been recognized for his teaching excellence, particularly in Human Genetics. Dr. Gross leads a research laboratory focused on evolutionary and developmental biology at the University of Cincinnati. His team employs a multidisciplinary approach combining field work in Mexican caves, laboratory experiments, genomic analysis, and developmental studies. He has organized international scientific meetings, including the Astyanax International Meeting, fostering collaboration among researchers studying cave-adapted organisms worldwide.
Dana Pe'er is a Professor and Chair of the Computational and Systems Biology Program at the Sloan Kettering Institute (SKI) of Memorial Sloan Kettering Cancer Center. She is also an Investigator of the Howard Hughes Medical Institute and holds the Alan and Sandra Gerry Endowed Chair. Dr. Pe'er leads an interdisciplinary research group that combines advanced genomics approaches with machine learning to address fundamental questions in biomedical science, with particular focus on cancer biology, developmental biology, and immunology. Dr. Pe'er earned her PhD from Hebrew University in Jerusalem, Israel. Her academic journey includes a postdoctoral fellowship with George Church at Harvard Medical School. Before joining Memorial Sloan Kettering Cancer Center in 2016, she held faculty positions at Columbia University. Dr. Pe'er's research focuses on understanding cellular plasticity, the consequences of intra-tumor heterogeneity, cancer evolution and metastasis, and the mechanisms by which regulatory circuits go awry in disease. Her lab combines single-cell and spatial profiling technologies with machine learning approaches to investigate gene regulation, cellular plasticity, and cell-cell communication in the contexts of cancer, immunity, and development. They are particularly interested in how organisms develop from a single cell to generate diverse cell types, how epigenetic control rewires during development, and how cells communicate to execute multicellular responses. Analysis of Dr. Pe'er's recent publications reveals a strong focus on developing computational methods for single-cell and spatial genomics data analysis. Her work spans cancer types including pancreatic, prostate, colorectal, and breast cancer, with emphasis on tumor heterogeneity, metastasis mechanisms, and cellular plasticity. A significant portion of her research involves creating novel algorithms and tools like CellRank, REUNION, and SEACells that enable researchers to extract meaningful biological insights from complex genomic datasets. 2023 Class of 2023 Inductee - American Academy of Cancer Research (AACR) Academy 2023 Innovator Award - International Society for Computational Biology (ISCB) 2021 Fellow - International Society for Computational Biology (ISCB) Howard Hughes Medical Institute Investigator (2021) 2019 Ernst W. Bertner Memorial Award - University of Texas MD Anderson Cancer Center 2016 Lenfest Distinguished Faculty Award - Columbia University 2014 Director's Pioneer Award - National Institutes of Health 2014 Overton Prize - International Society for Computational Biology (ISCB) Dr. Pe'er is known for her dedicated mentorship approach, describing herself as "a mama bear" who cares deeply about her trainees while expecting independence, innovation, and hard work. She mentors numerous PhD students and postdocs in her lab. Her HHMI Investigator award provides approximately $9 million over seven years, enabling ambitious research directions. She also collaborates extensively with the Single-cell Analytics and Innovation Lab (SAIL) at MSK to generate new data from emerging technologies, working closely with wet-lab collaborators at MSK and beyond to apply computational methods to cutting-edge datasets across multiple disease areas. The Pe'er Lab is an interdisciplinary group of computational biologists with diverse backgrounds ranging from pure mathematics to clinical medicine. They work closely with wet-lab collaborators to apply their computational methods to cutting-edge datasets across cancer, immunology, and developmental biology. The lab is described as open, supportive, collaborative, and fun, with access to world-class facilities at the Sloan Kettering Institute. Dr. Pe'er's work continues to push the boundaries of computational biology and cancer research, with the ultimate goal of developing more effective, personalized therapies for cancer patients.
Daniel J. Field is Professor of Vertebrate Palaeontology in the Department of Earth Sciences and the Strickland Curator of Ornithology at the University of Cambridge Museum of Zoology. He is a Fellow of Christ's College, Cambridge, where Charles Darwin studied as an undergraduate, and serves as the founding director of the Darwin-Hamied Centre at Christ's College. Field also maintains research associate positions at the Denver Museum of Nature and Science and the Natural History Museum (London). Field is an evolutionary biologist and palaeontologist whose research focuses on deciphering the origins of modern avian biodiversity using fossil, anatomical, and molecular data. His work spans multiple themes including clarifying how birds survived and diversified following the mass extinction of non-avian dinosaurs, studying the evolutionary histories of major living bird groups, and understanding the evolutionary origins of distinctive biological features such as the modern bird skull. In 2020, his team announced the discovery of Asteriornis maastrichtensis (the 'Wonderchicken'), the oldest-known modern bird fossil and an early relative of the group that gave rise to living chickens and ducks. Field's publication record shows consistent research output across multiple areas of avian evolution, with recent work focusing on avian palate evolution, skeletal pneumaticity, developmental patterns in bird skulls, and the evolutionary relationships among major bird groups. His research integrates cutting-edge techniques including CT scanning, geometric morphometrics, and phylogenetic analysis to address fundamental questions about vertebrate evolution. Field leads an active research group comprising postdoctoral researchers, PhD students, and master's students from around the world. His lab has produced significant work on topics including the evolution of flightlessness in ratites, the developmental underpinnings of avian morphological diversity, and the phylogenetic relationships among major bird lineages. The lab maintains strong international collaborations and has been instrumental in training the next generation of evolutionary biologists and palaeontologists. Field is passionate about natural history and science outreach, and enjoys photographing Earth's vertebrate biodiversity in the field. His work bridges the gap between traditional palaeontology and modern evolutionary biology, contributing significantly to our understanding of how modern bird diversity arose from their dinosaurian ancestors.
Dr. Ronald P. Strauss serves as the Adams Distinguished Professor at the University of North Carolina at Chapel Hill in the Adams School of Dentistry, with additional appointments as Professor of Social Medicine in the School of Medicine and Clinical Professor of Epidemiology in the Gillings School of Global Public Health. He concurrently holds the position of Chief Global Officer for the Adams School of Dentistry and is an active member of the UNC Craniofacial Center Team. His academic credentials include: BA in Biology from Queens College New York DMD from the University of Pennsylvania PhD in Sociology from the University of Pennsylvania Dr. Strauss's research examines the social dimensions of chronic health conditions, with specialized focus on craniofacial differences and HIV/AIDS. His interdisciplinary approach integrates clinical practice, sociological theory, ethical frameworks, and health policy analysis to address stigma, healthcare access barriers, prenatal diagnosis implications, and community engagement strategies. Methodologically, he employs qualitative ethnography and survey research to investigate psychosocial impacts. His scholarly output demonstrates consistent thematic focus across decades, with recent publications revealing intensified examination of structural determinants of health, intersectional disparities in craniofacial care, and innovative community-based HIV/AIDS interventions. Key patterns include transdisciplinary collaboration, emphasis on patient-centered outcomes, and critical analysis of systemic inequities in healthcare delivery. Dr. Strauss directs the campus-wide HIV/AIDS Course annually since 1987 and teaches Social and Health Systems to medical students. As Faculty Director of the CFAR Office of Community Engagement and lead of the Thorp Faculty Engaged Scholars Program, he mentors faculty in community-engaged scholarship while maintaining active clinical and research supervision. He maintains leadership within the UNC Craniofacial Center Team and has conducted international fieldwork across five countries, reflecting his commitment to global health equity through partnerships in Brazil, Israel, Thailand, Moldova, and China.
Zhi-Pei Liang is the Franklin W. Woeltge Professor in the Department of Electrical and Computer Engineering at the University of Illinois at Urbana-Champaign, with joint appointments in the Department of Bioengineering, Beckman Institute for Advanced Science and Technology, and Coordinated Science Laboratory. His research spans biomedical engineering, medical imaging, and signal processing with a focus on advancing magnetic resonance imaging and spectroscopy technologies. His educational background includes a Ph.D. in Biomedical Engineering from Case Western Reserve University (1989) and a B.S. in Electrical Engineering from South-China University of Technology (1982), followed by postdoctoral training at UIUC (1989-1991). Professor Liang's research interests center on magnetic resonance imaging and spectroscopy , with particular emphasis on ultrafast imaging techniques , model-based reconstruction methods , and the integration of physics-based modeling with machine learning . His pioneering work on SPICE (SPectroscopic Imaging by exploiting spatiospectral CorrElation) has revolutionized high-resolution metabolic brain imaging by enabling label-free molecular imaging through the marriage of spin physics and machine learning. His research spans pattern recognition, parameter estimation, image formation theory, and algorithms for medical imaging applications. Analysis of his recent publications reveals a strong focus on high-resolution metabolic imaging , particularly using SPICE methodology to map brain metabolism with unprecedented detail. His work bridges fundamental physics of magnetic resonance with advanced computational methods to overcome traditional limitations in imaging speed and resolution. Current research directions include J-resolved spectroscopic imaging, deuterium-based metabolic mapping, and multimodal integration of PET and MRSI for studying neurological disorders. Elected to International Academy of Medical and Biological Engineering (2012) Gold Medal, International Society for Magnetic Resonance in Medicine (2022) Technical Achievement Award, IEEE Engineering in Medicine and Biology Society (2014) Fellow, National Academy of Inventors (2021) Author of influential book 'Principles of Magnetic Resonance Imaging' (1999) President of IEEE Engineering in Medicine and Biology Society (2011-2012) Professor Liang has advised numerous students and postdocs in biomedical imaging research and has received multiple teaching honors including the Ronald W. Pratt Outstanding Teaching Award (2005) and multiple listings among UIUC's Excellent Teachers. His research has been supported by various grants from NIH, NSF, and other funding agencies. He leads the SPICE (Spectroscopic Imaging by exploiting spatiospectral Correlation) research group which focuses on developing novel imaging techniques that combine physics-based modeling with machine learning for ultrafast metabolic imaging. His laboratory, part of the Beckman Institute's Integrative Imaging Theme, collaborates extensively with clinical researchers at Carle Illinois College of Medicine and other institutions to translate advanced imaging techniques into clinical applications for neurological disorders, cancer, and metabolic diseases. Current projects focus on high-resolution mapping of brain metabolism in Alzheimer's disease, stroke, and brain tumors using novel MR spectroscopic imaging techniques.
Gary M. Shaw is the Rosemarie Hess Professor and Professor (Research) at Stanford University , with courtesy appointments in the Department of Epidemiology and Population Health and Department of Obstetrics & Gynecology - Maternal Fetal Medicine . He serves as Co-PI of the March of Dimes Prematurity Research Center at Stanford and PI of the California Center for Finding Causes and Preventives of Birth Defects . His research focuses on the Epidemiology of birth defects Gene-environment interactions in perinatal outcomes Nutritional factors in reproductive health . He has developed machine learning approaches for precision parenteral nutrition and predictive models for preterm birth, while investigating persistent metabolomic signatures following hypertensive pregnancy disorders. Shaw's recent work explores Climate change impacts on reproductive health Maternal-fetal immune interactions Epigenetic mechanisms in perinatal disease with applications of multiomics to neonatal intensive care units. As a member of Bio-X and the Maternal & Child Health Research Institute , he contributes to translational research networks while serving as Associate Editor for Birth Defects Research and American Journal of Medical Genetics . He supervises Med Scholar Project student Richard Liang Doctoral co-advisor for Saskia Comess and Richard Liang Master's advisor for Lenae Joe while leading the Division of Neonatology as Associate Chair for Clinical Research (2012-2025). His laboratory work integrates Metabolomic profiling Proteomic analysis Computational modeling Machine learning for biomedical data to advance neonatal care through precision medicine approaches.
Albert M. Berghuis is a Professor in the Department of Biochemistry at McGill University's Faculty of Medicine. His research focuses on structural mechanisms of antibiotic resistance and fungal pathogenesis using advanced techniques including X-ray crystallography, electron microscopy, and computational chemistry. His primary research interests include: Structural basis of antibiotic resistance mechanisms, particularly against aminoglycosides Development of novel antimicrobials through structure-based drug design Structural studies of fungal-specific metabolic pathways for antifungal drug discovery Enzyme mechanisms involving protein-small molecule interactions Analysis of his recent publications reveals a consistent focus on structural elucidation of resistance mechanisms, with particular emphasis on aminoglycoside-modifying enzymes and fungal targets. His work bridges structural biology with therapeutic development, showing strong translational potential in combating antimicrobial resistance. Professor Berghuis maintains the Berghuis Lab with facilities in both the McIntyre Medical Sciences Building and the Francesco Bellini Life Sciences Building. His laboratory employs integrated structural biology approaches to tackle pressing problems in infectious disease treatment.
Irina A. Anselm, MD is Assistant Professor of Neurology at Harvard Medical School and Director of the Mitochondrial Program at Boston Children's Hospital. She co-directs the Neurometabolic Program and serves as clinical expert for the hospital's Precision Medicine Service. Her work spans pediatric neurology , neurogenetics , and mitochondrial medicine . Medical School: St. Petersburg Pediatric Medical Academy (1984) Residency: University of Massachusetts Medical Center (1995) Fellowship: New England Medical Center (1998) Dr. Anselm specializes in mitochondrial disorders and neurometabolic syndromes affecting children. Her research focuses on genetic diagnosis , experimental therapies , and clinical management of these complex conditions. She leads clinical trials evaluating novel treatments like dichloroacetate (DCA) for lactic acidemia and collaborates with biotech companies on gene therapy approaches. Key publication areas include mitochondrial disease pathophysiology , neurodevelopmental genetic mutations , and experimental treatment outcomes . She has authored consensus guidelines for mitochondrial disease management and serves as reviewer for multiple journals including Journal of Pediatric Neurology and Current Pediatric Reviews .
Brendan A. Harley is the Robert W. Schaefer Professor in Chemical and Biomolecular Engineering at the University of Illinois at Urbana-Champaign (UIUC), with a joint appointment in the Carl R. Woese Institute for Genomic Biology. His research focuses on developing biomaterials to replicate complex tissue microenvironments, enabling insights into cell behavior during development, disease, and regeneration. He holds leadership roles in academic and professional organizations, including editorial positions for Science Advances and Tissue Engineering . Harley earned his SB from Harvard University (2000), SM/ScD from MIT (2002, 2006), and completed postdoctoral studies at Boston Children’s Hospital. **Education**: Sc.D., Massachusetts Institute of Technology, 2006 S.M., Massachusetts Institute of Technology, 2002 S.B., Harvard University, 2000 **Research Interests**: Engineering dynamic, spatially-patterned biomaterials to mimic extracellular matrices Regenerative repair of musculoskeletal tissues Biomaterial models of cancer microenvironments (e.g., glioblastoma) Artificial bone marrow systems for hematopoietic stem cell studies Harley’s work has produced over 100 peer-reviewed articles and co-authored a textbook Cellular Materials in Nature and Medicine . His lab develops materials for clinical applications, including osteochondral defect repair and craniofacial bone regeneration. Notable honors include the NSF CAREER Award (2013), AAAS Fellowship (2014), and AIMBE Fellowship (2019). **Awards/Recognition**: Fellow, AAAS (2014) Young Investigator Award, Society for Biomaterials (2014) Campus Distinguished Promotion Award, UIUC (2018) His research group emphasizes translational outcomes, with projects spanning biomaterial design, cancer modeling, and stem cell engineering. Collaborations include industry partners like Orthomimetics (acquired by TiGenix) and foundational studies on tumor microenvironments.
Blaine A. Jacobs, PhD, is an Associate Professor of Pharmacology at the University of the Incarnate Word School of Osteopathic Medicine (UIWSOM), joining the faculty in June 2018. She earned her doctorate in Pharmacology from UT Health Science Center at San Antonio, supported by the Craniofacial Oral-Biology Fellowship and Council for Excellence in Women's Health Scholarship. Her research examines opioid receptor mechanisms for pain management, migraine pathology, and socioeconomic disparities in healthcare. Current projects investigate pain management inequities in San Antonio and osteopathic interventions for underserved populations. She mentors student-led research on ZIP code-based health disparities and maternal-fetal outcomes. Awards recognize her graduate research on peripheral analgesic targets. Postdoctoral work at UT Dallas involved migraine studies and pharmaceutical compound screening.
Anthony Brown is an Associate Professor in the Department of Cell and Developmental Biology at Weill Cornell Medical College, part of the Graduate School of Medical Sciences. He has been a faculty member since 1987 and currently serves as Director of the Office of Medical Student Research. Education: B.A. in Natural Sciences (Genetics), University of Cambridge, 1977 M.A., University of Cambridge, 1980 Ph.D. in Molecular Biology, University of Edinburgh, 1982 Postdoctoral Fellow, University of California, San Francisco (with Harold Varmus) Postdoctoral Fellow, University of Strasbourg (with Pierre Chambon) Dr. Brown's research focuses on the Wnt family of signaling proteins and their roles in tissue development, homeostasis, and cancer. His work has significantly advanced the understanding of both canonical and non-canonical Wnt pathways, particularly in breast and colorectal cancers. He has shown that Wnt signaling contributes to oncogenesis through mechanisms involving stem-like cells, epithelial-to-mesenchymal transition, and crosstalk with other signaling cascades such as TGFβ. His research employs diverse models including cell culture, organoids, mouse models, and patient-derived tissues. His recent publications reveal a strong emphasis on Wnt signaling in cancer stem cells, metastasis, and signal transduction mechanisms. Trends include the role of Wnt in tumor microenvironments, regulation of ribosomal DNA, and therapeutic targeting of multiple pathways simultaneously. His work frequently appears in high-impact journals such as PNAS, Cancer Research, and Development. Scientific Awards: Royal Society European Science Exchange Fellowship Medical Research Council (U.K.) Travelling Fellowship Cornell Scholars Award Andrew W. Mellon Teacher-Scientist Award Pew Scholar in the Biomedical Sciences Irma T. Hirschl Career Scientist Award WCM Awards for Teaching Excellence WCM Awards for Excellence in Medical Education Dr. Brown has been actively involved in grant-funded research, including as a Co-Investigator on the Clinical and Translational Science Center (UL1) grant awarded by the National Center for Advancing Translational Sciences (2022–2027). He collaborates with a broad network of co-investigators across disciplines. He also mentors students and contributes to medical education, reflecting his dual commitment to research and teaching. His laboratory investigates Wnt signaling mechanisms and their implications for cancer therapeutics.
Amjad Javed is a Professor and Associate Dean at the University of Alabama at Birmingham , with primary appointments in the School of Dentistry - Oral & Maxillofacial Surgery and joint affiliations in Cell, Developmental and Integrative Biology , Otolaryngology , and Biomedical Engineering . His research spans bone biology, cartilage development, and myeloma bone disease. PhD in Physiology (University of the Punjab, 2003) MS in Zoology/Animal Biology (University of the Punjab, 1992) Research Interests focus on transcriptional regulation via RUNX2 and Sp7 in skeletogenesis, vascular calcification mechanisms, epigenetic control of bone formation, and tumor-bone microenvironment interactions in multiple myeloma. Key subfields include endochondral ossification, osteoclast differentiation, and nanomatrix-based tissue engineering. Scientific Contributions include discoveries about RUNX2's role in postnatal bone resorption, λ5 protein's impact on skeletal aging, and heparanase's promotion of myeloma metastasis. His work demonstrates RUNX2's dual function in chondrocyte apoptosis and cartilage degradation. Teaching & Mentorship involves graduate committee service for over 15 students and instruction in courses like Connective Tissue and Bone , Oral & Skeletal Biology , and Journal Clubs . Collaborations span Comprehensive Arthritis, Musculoskeletal, Bone and Autoimmunity Center , Integrative Center for Aging Research , and Biomatrix Eng Regen Med Center .
